Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes

3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes

US Patent 8153649 · Granted Apr 10, 2012

Estimated economic value: $132,429,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives2025
Quinolin-2-one derivatives2024
Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-me2024
Boronic acid derivatives2024
Benzimidazole derivatives as adenosine receptor antagonists2022
Boronic acid derivatives2022
Quinoxaline derivatives as adenosine receptor antagonists2021
Quinolin-2-one derivatives2021
Thiazolopyridine derivatives as adenosine receptor antagonists2021
Producing an aerosol-forming composition2021
Quinolin-2-one derivatives2021
Quinolin-2-one derivatives2020